Tamarly Intelligence
Private raises · SEC Form D

ADAPTIN BIO, INC.: $2 million Raised, SEC Form D Filings

Company · Biotechnology · NC · incorporated 2022 · SEC CIK 1938571

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
22 Jun 2026Amendment$4 million$2 millionBiotechnologyForm D
23 Mar 2026Amendment$4 million$2 millionBiotechnologyForm D
20 Feb 2026Amendment$4 million$1 millionBiotechnologyForm D
5 Jan 2026New notice$4 million$1 millionBiotechnologyForm D

Questions and answers

How much has ADAPTIN BIO, INC. raised?
ADAPTIN BIO, INC. reported $2 million sold in its largest Form D notice on file; its latest notice was filed on 22 June 2026. Form D amounts are what the issuer reported to the SEC.
What is ADAPTIN BIO, INC.?
ADAPTIN BIO, INC. is a company in biotechnology, based in Charlotte, North Carolina, incorporated in 2022, according to its SEC Form D filings.
How many Form D notices has ADAPTIN BIO, INC. filed?
4 notices between 5 January 2026 and 22 June 2026 in Tamarly's record, which starts on 1 October 2025.
Get an alert when ADAPTIN BIO, INC. files again, and see every Form D raise as it arrives; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "ADAPTIN BIO, INC.: SEC Form D filings", https://app.tamarly.ai/raisers/1938571, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.